What's in Robin, Alan L., M.D.'s pipeline?

Robin, Alan L., M.D. has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Robin, Alan L., M.D.'s portfolio?

Top competitors by shared drug class: Allergan, Formosa Pharmaceuticals, Inc., Medical University of Vienna, Ordination Dr. Hommer, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/robin-alan-l-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Robin, Alan L., M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robin, Alan L., M.D. pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Additional ocular hypotensive medication	Additional ocular hypotensive medication	marketed
travoprost, latanoprost, or bimatoprost	travoprost, latanoprost, or bimatoprost	marketed	Prostaglandin F receptor agonist	FP prostaglandin receptor	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
Formosa Pharmaceuticals, Inc. · 1 shared drug class
Medical University of Vienna · 1 shared drug class
Ordination Dr. Hommer · 1 shared drug class
Pfizer · 1 shared drug class
University Hospital, Basel, Switzerland · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Robin, Alan L., M.D.:

Cite this brief

Drug Landscape (2026). Robin, Alan L., M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/robin-alan-l-m-d. Accessed 2026-06-09.